SITAZID-M 50/500 is a scientifically formulated anti-diabetic medication combining Sitagliptin 50 mg BP and Metformin 500 mg SR (Sustained Release) to provide effective and balanced blood sugar management in individuals with Type 2 Diabetes Mellitus. Available in tablet form, this dual-action therapy supports comprehensive glucose control by improving insulin function and helping maintain stable blood sugar levels.

Designed for better diabetes management, SITAZID-M 50/500 helps regulate fasting blood glucose levels, improves insulin sensitivity, and offers a weight-neutral approach to treatment, supporting healthier long-term outcomes.